Imprint Wealth’s AbbVie ABBV Stock Holding History

Imprint Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10K	Sell	46 -79	-63%	-$17.5K	0.05%	123
2025 Q4	$28.6K	Buy	125 +45	+56%	+$10.3K	0.13%	76
2025 Q3	$18.5K	Buy	+80	New	+$16.3K	0.06%	136
2024 Q1	$3.93M	Buy	21,722 +5,276	+32%	+$909K	0.95%	19
2023 Q4	$2.55M	Buy	16,446 +51	+0.3%	+$7.43K	2.05%	8
2023 Q3	$2.44M	Buy	16,395 +601	+4%	+$88.2K	2.07%	9
2023 Q2	$2.13M	Sell	15,794 -1,171	-7%	-$172K	1.34%	15
2023 Q1	$2.69M	Buy	+16,965	New	+$2.59M	1.77%	10

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Imprint Wealth's ABBV Position: Q1 2026 in Review

Imprint Wealth reduced its AbbVie (ABBV) stake by 63% in Q1 2026, selling an estimated $17.5K and leaving 46 shares worth $10K. The position accounts for 0.05% of the portfolio, ranked #123.

Imprint Wealth first reported a position in ABBV in Q1 2023 and has held it in 8 quarters since. The position peaked at $3.93M in Q1 2024. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Imprint Wealth held 46 shares of AbbVie worth $10K as of Q1 2026.
Imprint Wealth sold 79 AbbVie shares in Q1 2026, an estimated $17.5K.
AbbVie made up 0.05% of Imprint Wealth's portfolio in Q1 2026, its #123 holding.
Imprint Wealth first reported a position in AbbVie in Q1 2023 and has held it in 8 quarters since.
Imprint Wealth's AbbVie position peaked at $3.93M in Q1 2024.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Imprint Wealth's 13F filing for Q1 2026, filed 15 May 2026.